摘要:
The invention concerns recombinantly produced parapoxviruses which carry in their genome deletions or insertions in the form of foreign hereditary information and contain other hereditary information. The invention also concerns the production of such constructs and their use in vaccines.
摘要:
The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
摘要:
A purified Parapoxvirus ovis envelope protein termed 'B2L' can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response to the B2L protein.
摘要:
The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.
摘要:
The invention concerns recombinantly produced parapoxviruses which carry in their genome deletions or insertions in the form of foreign hereditary information and contain other hereditary information. The invention also concerns the production of such constructs and their use in vaccines.
摘要:
The present invention relates to a recombinant Orf virus vector, a cell containing the recombinant Orf virus vector, a composition containing the recombinant Orf virus vector according to the invention and/or containing the cell according to the invention, the use of the recombinant Orf virus vector according to the invention for the production of a foreign gene. The invention also relates to a nucleic acid molecule coding for an Orf virus vector promoter.
摘要:
A method for treating a tumor by administering to a subject in need of such treatment an effective amount for treating the tumor of a Poxviridae decapping deficient mutant virus. Also disclosed are mutant Poxviridae and pharmaceutical formulations for use in the method.